A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech

wsj.com/health/pharma/a-new-shot-prevents-hivand-breathes-new-life-into-a-stagnant-biotech-6badbce9

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

This story appeared on wsj.com, 2025-06-05 09:30:00.
The Entire Business World on a Single Page. Free to Use →